Twinbeech Capital LP Regenxbio Inc. Transaction History

Twinbeech Capital LP

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2021 Aug 16, 2021	SELL	$32.46 - $40.48 $252,733 - $315,177	-7,786 Closed	0 $0
Q1 2021 May 17, 2021	BUY	$33.61 - $49.95 $261,687 - $388,910	7,786 New	7,786 $266,000
Q4 2020 Feb 16, 2021	SELL	$26.52 - $49.35 $240,642 - $447,801	-9,074 Closed	0 $0
Q3 2020 Nov 16, 2020	BUY	$27.01 - $40.26 $245,088 - $365,319	9,074 New	9,074 $250,000

192

42.6M

80.6K

55.2K

Ticker RGNX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 43,230,000
Market Cap $590M
Description
REGENXBIO Inc., a clinical-stage biotechnology company, provides gene therapy product candidates to deliver genes to cells to address genetic defects or to enable cells in the body to produce therapeutic proteins or antibodies that are intended to impact disease. Its gene therapy product candidates are based on NAV Technology Platform, a proprie...

Get notified when there are updates to the investment portfolio of Twinbeech Capital LP, based on Form 13F filings with the SEC.

Stay updated on Twinbeech Capital LP with notifications on news.